Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Rinsho Shinkeigaku ; 61(3): 194-199, 2021 Mar 25.
Article in Japanese | MEDLINE | ID: mdl-33627586

ABSTRACT

All three patients were men in their 70s. All cases were solitary onset and the chief complaint was gait disturbance. All patients had miosis and limb and trunk ataxia, MMSE score was declined in two patients, and FAB score was declined in all patients. Head MRI showed leukoencephalopathy, cerebellar atrophy, and DWI high intensity signal in corticomedullary junction. However, two of the three patients were not followed up without further examination. Skin biopsies in all cases showed ubiquitin-positive and p62-positive intranuclear inclusions. Genetic testing showed CGG repeat expansion of NOTCH2NLC. The diagnosis of neuronal intranuclear inclusion disease (NIID) was made based on the above findings in all cases. Most patients are diagnosed with NIID due to memory loss, but sometimes they are diagnosed due to gait disturbance with ataxia. It is important to proceed with the diagnosis by skin biopsy and genetic diagnosis based on the characteristic MRI findings of the head.


Subject(s)
Neurodegenerative Diseases/diagnosis , Neurodegenerative Diseases/pathology , Aged , Ataxia/etiology , Atrophy , Biopsy , Brain/diagnostic imaging , Brain/pathology , Gait Disorders, Neurologic/etiology , Genetic Testing , Humans , Intranuclear Inclusion Bodies/genetics , Intranuclear Inclusion Bodies/immunology , Intranuclear Inclusion Bodies/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Neurodegenerative Diseases/complications , Neurodegenerative Diseases/genetics , Receptor, Notch2/genetics , Skin/pathology , Trinucleotide Repeat Expansion
2.
Nat Commun ; 11(1): 1625, 2020 04 02.
Article in English | MEDLINE | ID: mdl-32242017

ABSTRACT

Aggregate-like biomolecular assemblies are emerging as new conformational states with functionality. Aire, a transcription factor essential for central T cell tolerance, forms large aggregate-like assemblies visualized as nuclear foci. Here we demonstrate that Aire utilizes its caspase activation recruitment domain (CARD) to form filamentous homo-multimers in vitro, and this assembly mediates foci formation and transcriptional activity. However, CARD-mediated multimerization also makes Aire susceptible to interaction with promyelocytic leukemia protein (PML) bodies, sites of many nuclear processes including protein quality control of nuclear aggregates. Several loss-of-function Aire mutants, including those causing autoimmune polyendocrine syndrome type-1, form foci with increased PML body association. Directing Aire to PML bodies impairs the transcriptional activity of Aire, while dispersing PML bodies with a viral antagonist restores this activity. Our study thus reveals a new regulatory role of PML bodies in Aire function, and highlights the interplay between nuclear aggregate-like assemblies and PML-mediated protein quality control.


Subject(s)
Polyendocrinopathies, Autoimmune/immunology , T-Lymphocytes/immunology , Transcription Factors/chemistry , Transcription Factors/genetics , Animals , Cell Nucleus/genetics , Cell Nucleus/immunology , Gene Expression Regulation , Humans , Immune Tolerance , Intranuclear Inclusion Bodies/genetics , Intranuclear Inclusion Bodies/immunology , Mice , Polyendocrinopathies, Autoimmune/genetics , Promyelocytic Leukemia Protein/genetics , Promyelocytic Leukemia Protein/immunology , Protein Domains , Transcription Factors/immunology , Transcription, Genetic , AIRE Protein
3.
J Cell Biol ; 201(2): 325-35, 2013 Apr 15.
Article in English | MEDLINE | ID: mdl-23589495

ABSTRACT

Important insights into nuclear function would arise if gene loci physically interacting with particular subnuclear domains could be readily identified. Immunofluorescence microscopy combined with fluorescence in situ hybridization (immuno-FISH), the method that would typically be used in such a study, is limited by spatial resolution and requires prior assumptions for selecting genes to probe. Our new technique, immuno-TRAP, overcomes these limitations. Using promyelocytic leukemia nuclear bodies (PML NBs) as a model, we used immuno-TRAP to determine if specific genes localize within molecular dimensions with these bodies. Although we confirmed a TP53 gene-PML NB association, immuno-TRAP allowed us to uncover novel locus-PML NB associations, including the ABCA7 and TFF1 loci and, most surprisingly, the PML locus itself. These associations were cell type specific and reflected the cell's physiological state. Combined with microarrays or deep sequencing, immuno-TRAP provides powerful opportunities for identifying gene locus associations with potentially any nuclear subcompartment.


Subject(s)
Chromatography, Affinity/methods , Genetic Association Studies , Genetic Loci , Intranuclear Inclusion Bodies/genetics , Intranuclear Inclusion Bodies/immunology , Leukemia, Promyelocytic, Acute/genetics , Leukemia, Promyelocytic, Acute/pathology , Chromatin/metabolism , DNA, Neoplasm/genetics , DNA, Neoplasm/isolation & purification , Humans , Immunosorbent Techniques , In Situ Hybridization, Fluorescence , Intranuclear Inclusion Bodies/ultrastructure , Jurkat Cells , Organ Specificity , Promoter Regions, Genetic/genetics
4.
J Virol ; 86(15): 8245-58, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22623778

ABSTRACT

Currently, the spatial distribution of human respiratory syncytial virus (hRSV) proteins and RNAs in infected cells is still under investigation, with many unanswered questions regarding the interaction of virus-induced structures and the innate immune system. Very few studies of hRSV have used subcellular imaging as a means to explore the changes in localization of retinoic-acid-inducible gene-I (RIG-I)-like receptors or the mitochondrial antiviral signaling (MAVS) protein, in response to the infection and formation of viral structures. In this investigation, we found that both RIG-I and melanoma differentiation-associated gene 5 (MDA5) colocalized with viral genomic RNA and the nucleoprotein (N) as early as 6 h postinfection (hpi). By 12 hpi, MDA5 and MAVS were observed within large viral inclusion bodies (IB). We used a proximity ligation assay (PLA) and determined that the N protein was in close proximity to MDA5 and MAVS in IBs throughout the course of the infection. Similar results were found with the transient coexpression of N and the phosphoprotein (P). Additionally, we demonstrated that the localization of MDA5 and MAVS in IBs inhibited the expression of interferon ß mRNA 27-fold following Newcastle disease virus infection. From these data, we concluded that the N likely interacts with MDA5, is in close proximity to MAVS, and localizes these molecules within IBs in order to attenuate the interferon response. To our knowledge, this is the first report of a specific function for hRSV IBs and of the hRSV N protein as a modulator of the innate immune response.


Subject(s)
Adaptor Proteins, Signal Transducing/immunology , DEAD-box RNA Helicases/immunology , Immunity, Innate , Intranuclear Inclusion Bodies/immunology , Nucleoproteins/immunology , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Virus, Human/immunology , Viral Proteins/immunology , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Animals , Birds , Cell Line, Tumor , Chlorocebus aethiops , DEAD Box Protein 58 , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/metabolism , Genome, Viral/genetics , Genome, Viral/immunology , Humans , Interferon-Induced Helicase, IFIH1 , Interferon-beta/biosynthesis , Interferon-beta/genetics , Interferon-beta/immunology , Intranuclear Inclusion Bodies/genetics , Intranuclear Inclusion Bodies/metabolism , Intranuclear Inclusion Bodies/pathology , Intranuclear Inclusion Bodies/virology , Newcastle Disease/genetics , Newcastle Disease/immunology , Newcastle Disease/metabolism , Newcastle Disease/pathology , Newcastle disease virus/genetics , Newcastle disease virus/immunology , Newcastle disease virus/metabolism , Nucleoproteins/genetics , Nucleoproteins/metabolism , RNA, Messenger/genetics , RNA, Messenger/immunology , RNA, Messenger/metabolism , RNA, Viral/genetics , RNA, Viral/immunology , RNA, Viral/metabolism , Receptors, Immunologic , Respiratory Syncytial Virus Infections/genetics , Respiratory Syncytial Virus Infections/metabolism , Respiratory Syncytial Virus Infections/pathology , Respiratory Syncytial Virus, Human/genetics , Respiratory Syncytial Virus, Human/metabolism , Vero Cells , Viral Proteins/genetics , Viral Proteins/metabolism
5.
Neuropathol Appl Neurobiol ; 38(4): 322-8, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21883376

ABSTRACT

AIMS: Recent studies have shown that fused-in-sarcoma (FUS) protein is a component of 'neuronal' intranuclear inclusion bodies (INIBs) in the brains of patients with intranuclear inclusion body disease (INIBD). However, the extent and frequency of FUS-immunoreactive structures in INIBD are uncertain. METHODS: We immunohistochemically examined the brain, spinal cord and peripheral ganglia from five patients with INIBD and five control subjects, using anti-FUS antibodies. RESULTS: In controls, the nuclei of both neurones and glial cells were intensely immunolabelled with anti-FUS and neuronal cytoplasm was weakly positive for FUS. In INIBD, neuronal and glial INIBs in the brain and spinal cord were positive for FUS. FUS-positive INIBs were also found in the peripheral ganglia. The proportion of FUS-positive neuronal INIBs relative to the total number of inclusion-bearing neurones ranged from 55.6% to 83.3% (average 73.2%) and that of FUS-positive glial INIBs ranged from 45.9% to 85.7% (average 62.7%). The nucleus and cytoplasm of inclusion-bearing neurones and glial cells showed no FUS immunoreactivity. CONCLUSIONS: These findings suggest that FUS is incorporated into INIBs in both neurones and glial cells and that loss of normal FUS immunoreactivity may result from reduced protein expression and/or sequestration within inclusions.


Subject(s)
Intranuclear Inclusion Bodies/metabolism , Neurodegenerative Diseases/metabolism , Neuroglia/metabolism , Neurons/metabolism , RNA-Binding Protein FUS/metabolism , Aged , Brain/immunology , Brain/metabolism , Brain/pathology , Female , Humans , Immunohistochemistry , Intranuclear Inclusion Bodies/immunology , Intranuclear Inclusion Bodies/pathology , Middle Aged , Neurodegenerative Diseases/immunology , Neurodegenerative Diseases/pathology , Neuroglia/immunology , Neuroglia/pathology , Neurons/immunology , Neurons/pathology , RNA-Binding Protein FUS/immunology , Spinal Cord/immunology , Spinal Cord/metabolism , Spinal Cord/pathology
6.
Protein Expr Purif ; 47(2): 341-7, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16510294

ABSTRACT

Tuberculosis remains a major infectious disease with over 8 million new cases and 2 million deaths annually. Therefore, a vaccine more potent than BCG is desperately needed. In this regard, an approximately 800 bp DNA encoding a mycobacterial synthetic gene designated as VacIII (containing ubiquitin gene UbGR and four immunogenic mycobacterial epitopes or genes of ESAT-6, Phos1, Hsp 16.3, and Mtb8.4) was sub-cloned into a bacterial expression vector of pRSET-B resulting in a 6 x His-VacIII fusion gene construction. This recombinant clone was over expressed in Escherichia coli BL-21 (DE-3). The expressed fusion protein was found almost entirely in the insoluble form (inclusion bodies) in cell lysate. The inclusion bodies were solubilized with 8M urea and the recombinant protein was purified by Ni-NTA column and dialyzed by urea gradient dialysis. This method produced a relatively high yield of recombinant VacIII protein and the cloned VacIII gene offers the potential development of other vaccine formats such as DNA vaccine and recombinant vaccine.


Subject(s)
Antigens, Bacterial/biosynthesis , Mycobacterium tuberculosis/genetics , Recombinant Fusion Proteins/biosynthesis , Tuberculosis Vaccines/biosynthesis , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Antigens, Bacterial/isolation & purification , Cloning, Molecular , Escherichia coli/genetics , Gene Expression , Intranuclear Inclusion Bodies/immunology , Intranuclear Inclusion Bodies/metabolism , Mycobacterium tuberculosis/immunology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/isolation & purification , Tuberculosis Vaccines/genetics , Tuberculosis Vaccines/immunology , Tuberculosis Vaccines/isolation & purification , Vaccines, Acellular/biosynthesis , Vaccines, Acellular/genetics , Vaccines, Acellular/immunology , Vaccines, Acellular/isolation & purification
7.
Arkh Patol ; 68(1): 3-6, 2006.
Article in Russian | MEDLINE | ID: mdl-16544526

ABSTRACT

Cytomegalovirus (CMV) infection is widely spread among population. While immunocompetent patients suffer rarely from this virus, it can lead to a lethal outcome in immunocompromised patients. An electron microscopic study has detected fibroblastic morphological changes of a definite cytodestructive character. The nuclei of some fibroblasts have chromatine condensation. A clear zone arising due to vacuolization near this inclusion may reflect nuclear rearrangement leading to further CMV metamorphosis of the cell. This metamorphosis is characteristic of the changes developing in the cells of different parenchymatous organs.


Subject(s)
Chromatin/ultrastructure , Cytomegalovirus Infections/pathology , Fibroblasts/ultrastructure , Inclusion Bodies, Viral/ultrastructure , Intranuclear Inclusion Bodies/ultrastructure , Chromatin/immunology , Chromatin/virology , Cytomegalovirus Infections/immunology , Cytomegalovirus Infections/mortality , Fibroblasts/immunology , Fibroblasts/virology , Humans , Immunocompromised Host/immunology , Inclusion Bodies, Viral/immunology , Inclusion Bodies, Viral/virology , Intranuclear Inclusion Bodies/immunology , Intranuclear Inclusion Bodies/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...